6 hours ago
Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?
US President Donald Trump’s announcement of a phased tariff regime on generic drug imports starting at zero per cent but climbing to 100 per cent and eventually 200 per cent by 2028 has put India’s pharmaceutical industry on alert. Trump said that... Read more.
Owner: Iqbal Survé through Sekunjalo Investments; Chinese Government through China International Television Corporation & The China Africa Development Fund; South African Government through The Public Investment Corporation of South Africa
Owner: Chinese Government through The State Council of the People's Republic of China
Owner: John Tang (Founder & CEO) through Epoch Media Group
More from The Economic Times
Owner: Sahu Jain Family through Bennett, Coleman & Company Ltd
Owner: Sahu Jain Family through Bennett, Coleman & Company Ltd
Owner: Sahu Jain Family through Bennett, Coleman & Company Ltd
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
